Drawing for Serial No. 79411083

USPTO serial 79411083

Serial No. 79411083

Reviewed by CopyMark Law Group

Reg. 8290082Status 700Registered
Filing date
Status date
Registration date
Jun 9, 2026
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79411083?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miki Motohashi Iino

Miki Motohashi Iino Millen, White, Zelano & Branigan, P.C.2200 Clarendon Boulevard Suite 1400Arlington, VA 22201United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements and dietetic preparations adapted for medical purposes; pharmaceutical preparations for the treatment of cough and cold and neuropsychiatric disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, and kidney diseases and natural remedy preparations for the treatment of cough and cold and neuropsychiatric disorders; natural remedies for skin care, women's health, gastrointestinal health and nephrology, namely, natural herbal supplements, natural dietary supplements, natural remedy preparations for the treatment of gastrointestinal diseases and conditions; vitamin and mineral preparations for medical use; veterinary preparations and substances for the treatment of infectious diseases and bacterial and viral infections; pharmaceutical preparations for veterinary use for the treatment of infectious diseases and bacterial and viral infections; pharmaceutical preparations for animals for the treatment of infectious diseases and bacterial and viral infections; nutritional supplements for veterinary use; medicinal healthcare preparations being medicinal herbal preparations; medicines for veterinary purposes for the treatment of infectious diseases and bacterial and viral infections; medical preparations for the treatment of cough and cold and neuropsychiatric disorders; medical preparations for skin care, women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, and kidney diseases; chemical preparations for veterinary purposes, namely, for the treatment of cough and cold and neuropsychiatric disorders; chemical preparations for medical purposes, namely, for the treatment of cough and cold and neuropsychiatric disorders; chemical preparations for medical purposes, namely, for skin care, women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, and kidney diseasesACTIVE—
042Science and technology services, namely, scientific research, product research and development for healthcare applications; testing, authentication and quality control of healthcare applications, namely, product testing, material testing, authentication in the field of medical devices, quality control for others, quality control of goods and services; research in the field of energy; research and development in the field of biotechnology; research and development of new products; research and development services in the field of healthcare and biotechnology, namely, product research and development, scientific research and development, pharmaceutical research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 9, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 9, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 14, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 27, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 26, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 26, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 26, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 15, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 15, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 15, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2025RFNTREFUSAL PROCESSED BY IB—
May 12, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 12, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 22, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 21, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2025DOCKASSIGNED TO EXAMINER—
Nov 29, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 29, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance